Finance

House committee directs Pentagon plan for radiation drugs

SpaceX is about to make history—and 80% of VCs won’t see a dime of it

J&J expands US rollout of TECNIS PureSee cataract lens

SpaceX is about to make history—and 80% of VCs won’t see a dime of it

Thomson Reuters elects 14 directors including two new members

SpaceX is about to make history—and 80% of VCs won’t see a dime of it

Needham raises Navan stock price target to $30 on strong growth

SpaceX is about to make history—and 80% of VCs won’t see a dime of it

Leerink downgrades Procept BioRobotics stock rating on competition